Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
Patents for C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups (27,160)
11/2005
11/23/2005CN1228322C 2,5-dimethoxy-4-[2'-fluorosulphuric radical]-beta-nitro-styrene and its preparation and uses
11/23/2005CN1228321C Synthesis method of 2-[2'-fluorosulphuric radical] teredimethyl ether
11/23/2005CN1228320C Preparation process of 2,5-dimethoxy-4-ethyl sulfide-beta-nitrostyrolene
11/23/2005CN1228319C synthesis method of 2,5-dimethoxy ethyl phenyl sulfide
11/22/2005US6967196 Sulfonamide compounds and uses thereof
11/22/2005CA2187174C .alpha.-substituted phenylacetic acid derivative, process for producing the same, and agricultural bactericide containing the same
11/22/2005CA2068066C Herpesvirus particles and vaccine
11/17/2005WO2005108338A1 Novel therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders
11/17/2005WO2005108330A1 Metal complexes based on tetrathiol ligands and their use in nuclear medical diagnostics and endoradionuclide therapy and method for producing said metal complexes
11/17/2005US20050256333 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis
11/17/2005US20050256198 2-[(4-{3-[benzyl(hexyl)amino]-3-oxopropyl}phenoxy)methyl]benzoic acid;peroxisome proliferator-activated receptors alfa agonist; antidiabetic, hypotensive agent; obesity, elevated VLDL (Very Low Density Lipoproteins) and reduced HDL (High Density Lipoprotein) concentrations
11/17/2005US20050256133 Thio-substituted arylmethanesulfinyl derivatives
11/17/2005US20050256132 Use of ER selective NF-kB inhibitors for the treatment of sepsis
11/17/2005US20050256116 Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
11/17/2005US20050255582 Surface modifying composition
11/17/2005US20050255575 Reacting a vinyl halide and an acetylene compound in the presence of a copper (1) bidentate ligand complex, e.g., Cu(1,10-phenanthrolene)(triphenylphosphine)2NO3 and a CuI/neocuproine reaction product; free of expensive palladium reagents
11/17/2005US20050253415 Vehicle and a vehicle door
11/17/2005DE19625376B4 Bis(chlorsulfonylphenyl)perfluoralkyliden-Verbindung und deren Verwendung Bis (chlorosulfonylphenyl) perfluoroalkylidene compound and the use thereof
11/16/2005EP1594837A1 Compounds which are modulators of the ppar-type receptors and their use in cosmetic or pharmaceutical compositions
11/16/2005EP1594824A2 Process of preparing esters and ethers of probucol and derivatives thereof
11/16/2005EP1317426B1 Beta-thio-amino acids
11/16/2005EP0944583B1 Novel compounds useful as therapeutic agents and assay reagents
11/16/2005CN1227223C Process for the production of methionine
11/15/2005US6964983 Compounds that modulate PPAR activity and methods for their preparation
11/15/2005CA2130944C Ortho-substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
11/15/2005CA2123860C New herbicides
11/10/2005WO2005105770A2 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
11/10/2005WO2005105764A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/10/2005WO2005105744A1 Histamine-3 receptor antagonists
11/10/2005WO2005105737A1 Process for the preparation of substituted tetralin and substituted indane derivatives
11/10/2005WO2005105736A1 Novel compounds, their preparation and use
11/10/2005WO2005105735A1 Phenoxyacetic acid derivatives as ppar agonists
11/10/2005WO2005105726A1 Novel compounds, their preparation and use
11/10/2005WO2005105725A1 Novel compounds, their preparation and use
11/10/2005WO2005105724A1 Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
11/10/2005WO2005105717A1 Process for the production of cyclic diketones
11/10/2005WO2005095326A3 2-amino- and 2-thio-substituted 1,3-diaminopropanes
11/10/2005WO2005058298A3 Fk228 analogs and their use as hdac-inhibitors
11/10/2005US20050250959 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/10/2005US20050250949 Intermediates useful in the synthesis of HIV-protease inhibitors and methods for preparing the same
11/10/2005US20050250824 Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient
11/10/2005US20050250822 Substituted benzanilide compound and noxious organism controlling agent
11/10/2005US20050250816 Positive allosteric modulators of the nicotinic acetylcholine receptor
11/10/2005US20050250768 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
11/10/2005US20050250744 Pharmaceutically active compounds and methods of use thereof
11/10/2005CA2565184A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/10/2005CA2564558A1 Process for the preparation of substituted tetralin and substituted indane derivatives
11/10/2005CA2564258A1 Histamine-3 receptor antagonists
11/10/2005CA2562176A1 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
11/09/2005EP1593707A1 Rubber vulcanization agents based on sulfur- and nitrogen-containing compounds
11/09/2005EP1593671A1 DPP-IV inhibitors
11/09/2005EP1592660A1 Acylated aminopropanediols and analogues and therapeutic uses thereof
11/09/2005EP1313700B1 10-aryl-11h-benzo[b]fluorene derivatives and analogs as estrogenic compounds
11/09/2005EP1218366B8 Method for producing cox-2 inhibitors
11/09/2005EP1216223B1 Novel dicarboxylic acid derivatives with pharmaceutical properties
11/09/2005EP1212296B1 Phosphate mimics and methods of treatment using phosphatase inhibitors
11/09/2005EP1100788B1 Substituted quinazoline derivatives
11/09/2005EP1095016B1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
11/09/2005CN1693998A Hydrazone-based charge transport materials
11/09/2005CN1693996A Hydrazone-based charge transport materials
11/09/2005CN1226289C L-cystine extracting process
11/09/2005CN1226288C Novel synthesis technology of N-methyl-2-methyl-3-thia-5-chlorovaleryl amine
11/09/2005CN1226287C Method for preparing thiobisphenol oligomer with special meltling point and melting range
11/09/2005CN1226284C N-sulphonyl and N-sulphinyl phenylglycinamide
11/09/2005CN1226277C Phenacylamine derivatives, production thereof and pest controllers containing the derivatives
11/08/2005US6962929 Drugs such as 4-(N,N-Dimethylamino)-1-pentafluorophenyl-sulfonamidobenzene and/or prodrugs, used as anticarcinogenic agents, microbiocides or bactericides; tubulin inhibitors
11/03/2005WO2005103027A1 Synthesising method and benzoxathiepine intermediates
11/03/2005WO2005102989A1 Non-nucleoside reverse transcriptase inhibitors
11/03/2005WO2005102985A1 Process for preparation of probucol derivatives
11/03/2005WO2005102323A2 Process of preparing esters and ethers of probucol and derivatives thereof
11/03/2005WO2005080309A8 Stereoselective synthesis of a 4,4-disubstituted cyclohexanepropanoic acid
11/03/2005US20050245747 e.g. 2-[2-(5-chloro-benzo[b]thiophen-2-yl)-phenylmethanesulfinyl]-acetamide; autoimmune disorders, antidepressant; narcolepsy, Parkinson's, Alzheimer's disease; attention deficit hyperactivity disorder; sleep disorder, fatigue
11/03/2005US20050245702 nickel, palladium, iron or cobalt complexes with neutral ligands that contain one or both of the imino (C=N) or phosphinidine (C=P) or (P-C=N) groups; polymerization of ethylene for example
11/03/2005US20050245607 N-bisaryl- and n-aryl-cylcloakylidenyl-alpha-hydroxy-and alpha-alkoxy acid amides
11/03/2005US20050245543 Histamine-3 receptor antagonists
11/03/2005US20050245432 N-methyl amino acids
11/03/2005US20050244733 Hydrazone-based charge transport materials
11/03/2005US20050244732 Hydrazone-based charge transport materials
11/03/2005CA2563180A1 Non-nucleoside reverse transcriptase inhibitors
11/03/2005CA2562354A1 Synthesising method and benzoxathiepine intermediates
11/02/2005EP1591837A1 Hydrazone-based charge transport materials
11/02/2005EP1591836A1 Hydrazone-based charge transport materials
11/02/2005EP1591834A2 Azine-based charge transport materials
11/02/2005EP1590340A1 Inhibitors of histone deacetylase
11/02/2005EP1196371B1 Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity
11/02/2005CN1692098A Sulfonamide derivatives, insecticides for agricultural and horticultural use, and usage thereof
11/02/2005CN1690868A Azine-based charge transport materials
11/02/2005CN1690048A Curing agent based on organic sulfur-nitrogen compound for unsaturated rubber and its mixture
11/01/2005US6960692 Diaryl sulfide derivative, addition salt thereof, and immunosuppressant
11/01/2005US6960688 Use of compounds for the elevation of pyruvate dehydrogenase activity
11/01/2005US6960685 histone deacetylase; antiproliferative agents; psoriasis, cancer; N-Hydroxy-2-(4-Isopropyl-phenylcarbamoyl)-methoxy)-acetamide
11/01/2005US6960683 Antiinflammatory agents; autoimmune diseases; cardiovascular disorders
11/01/2005CA2177586C 4-benzoylisoxazoles and their use as herbicides
10/2005
10/27/2005WO2005100345A1 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
10/27/2005WO2005100311A1 Bicyclic aromatic sulfinyl derivatives
10/27/2005WO2005100310A1 Thio-substituted arylmethanesulfinyl derivatives
10/27/2005WO2005100309A1 Tricyclic aromatic and bis-phenyl sulfinyl derivatives
10/27/2005WO2005100308A1 Thio-substituted biaryl-methanesulfinyl derivatives
10/27/2005WO2005100305A1 Androgen modulators
10/27/2005WO2005100301A1 2-aryloxyethyl glycine derivatives and their use as glycine transport inhibitors
1 ... 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 ... 272